{"id":"W2088802427","doi":"10.1016/j.jaad.2009.05.042","title":"A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti–interferon-alfa monoclonal antibody, in subjects with chronic psoriasis","year":2010,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":80,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research; Innovaderm (Canada)","funders":"","keywords":"Medicine; Psoriasis; Placebo; Monoclonal antibody; Interferon alfa; Double blind; Monoclonal; Internal medicine; Placebo-controlled study; Interferon; Antibody; Dermatology; Immunology; Gastroenterology; Alpha interferon; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001409784,0.001808648,0.003814405,0.000683276,0.0008188963,0.000992562,0.001272723,0.002358102,0.007511285],"category_scores_gemma":[0.001574722,0.001194104,0.001533129,0.0004370192,0.001597194,0.001139253,0.0004533421,0.003201212,0.001504106],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006938041,"about_ca_system_score_gemma":0.001100324,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001552928,"about_ca_topic_score_gemma":0.00267151,"domain_scores_codex":[0.9995157,0.0002034484,0.00003264382,0.0001085614,0.00004057501,0.00009903346],"domain_scores_gemma":[0.9992698,0.0002021046,0.000113706,0.00006741905,0.0000523331,0.0002946313],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9790029,0.00927223,0.0002508717,0.0002874226,0.0003817497,0.00002093414,0.00003274317,0.0001245404,0.003460999,0.00005283041,0.0003529357,0.006759771],"study_design_scores_gemma":[0.9574937,0.04084106,0.0008695999,0.000009623844,0.0001956768,0.00001084937,0.0000118982,0.000117097,0.0002142064,0.00004254127,0.0001858252,0.000007947638],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9856045,0.003258978,0.001087581,0.0006700183,0.0008319881,0.004781418,0.0009519493,0.0002354709,0.002578094],"genre_scores_gemma":[0.9846218,0.002624503,0.001877904,0.001680261,0.0007249748,0.003956421,0.001091528,0.0000375725,0.003385097],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007511285,"threshold_uncertainty_score":0.02512777,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02083832315846544,"score_gpt":0.3237111434332171,"score_spread":0.3028728202747516,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}